NCT00753415 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 10
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 10
- group Id
- BG005
- value
- 37
- units
- Participants
- groups
- description
- Two IM injections of V935 low dose (LD), 1 given every other week over a 3-week period.
- id
- BG000
- title
- Part A: V935 LD
- description
- Three electroporation (EP) injections of V934 (LD) were administered, 1 given every other week over a 5-week period. Following a 4 week observation period, 2 IM injections of V935 (LD) were administered, 1 given every other week over a 3-week period.
- id
- BG001
- title
- Part A: V934 LD(3)+V935 LD
- description
- Two IM injections of V935 high dose (HD), 1 given very other week over a 3-week period.
- id
- BG002
- title
- Part A: V935 HD
- description
- Three EP injections of V934 (HD) were administered, 1 given every other week over a 5-week period. Following a 4 week observation period, 2 IM injections of V935 (HD) were administered, 1 given every other week over a 3-week period.
- id
- BG003
- title
- Part A: V934 HD(3)+V935 HD
- description
- Five EP injections of V934 (HD) were administered, 1 given every other week over a 9-week period. Following a 4-week observation period, 2 IM injections of V935 (HD) were administered, 1 given every other week over a 3-week period.
- id
- BG004
- title
- Part A: V934 HD(5)+V935 HD
- description
- Total of all reporting groups
- id
- BG005
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.5
- value
- 70.0
- group Id
- BG001
- spread
- 6.2
- value
- 70.0
- group Id
- BG002
- spread
- 10.0
- value
- 63.8
- group Id
- BG003
- spread
- 11.7
- value
- 58.8
- group Id
- BG004
- spread
- 11.7
- value
- 60.2
- group Id
- BG005
- spread
- 11.0
- value
- 62.4
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 10
- title
- Female
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 9
- group Id
- BG005
- value
- 27
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 10
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 10
- group Id
- BG005
- value
- 37
- units
- Participants
- groups
- description
- Two IM injections of V935 low dose (LD), 1 given every other week over a 3-week period.
- id
- BG000
- title
- Part A: V935 LD
- description
- Three electroporation (EP) injections of V934 (LD) were administered, 1 given every other week over a 5-week period. Following a 4 week observation period, 2 IM injections of V935 (LD) were administered, 1 given every other week over a 3-week period.
- id
- BG001
- title
- Part A: V934 LD(3)+V935 LD
- description
- Two IM injections of V935 high dose (HD), 1 given very other week over a 3-week period.
- id
- BG002
- title
- Part A: V935 HD
- description
- Three EP injections of V934 (HD) were administered, 1 given every other week over a 5-week period. Following a 4 week observation period, 2 IM injections of V935 (HD) were administered, 1 given every other week over a 3-week period.
- id
- BG003
- title
- Part A: V934 HD(3)+V935 HD
- description
- Five EP injections of V934 (HD) were administered, 1 given every other week over a 9-week period. Following a 4-week observation period, 2 IM injections of V935 (HD) were administered, 1 given every other week over a 3-week period.
- id
- BG004
- title
- Part A: V934 HD(5)+V935 HD
- description
- Total of all reporting groups
- id
- BG005
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.5
- value
- 70.0
- group Id
- BG001
- spread
- 6.2
- value
- 70.0
- group Id
- BG002
- spread
- 10.0
- value
- 63.8
- group Id
- BG003
- spread
- 11.7
- value
- 58.8
- group Id
- BG004
- spread
- 11.7
- value
- 60.2
- group Id
- BG005
- spread
- 11.0
- value
- 62.4
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 10
- title
- Female
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 9
- group Id
- BG005
- value
- 27
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle